Antiretroviral therapy and medical management of the human immunodeficiency virus-infected child. Working Group on Antiretroviral Therapy: National Pediatric HIV Resource Center.
D017088:AIDS-Related Opportunistic Infections / Q000517:prevention & control; D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D016049:Didanosine / Q000627:therapeutic use; D015658:HIV Infections / Q000175:diagnosis / Q000178:diet therapy / Q000188:drug therapy*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007223:Infant; D016047:Zalcitabine / Q000627:therapeutic use; D015215:Zidovudine / Q000009:adverse effects / Q000627:therapeutic use*
D000998:Antiviral Agents; D016756:Immunoglobulins, Intravenous; D015215:Zidovudine; D016047:Zalcitabine; D016049:Didanosine